Phase III Study to Evaluate the Efficacy and Safety of AD-209

A Multicenter, Randomized, Double-blind, Active-control, Phase III Study to Evaluate the Efficacy and Safety of AD-209 in Patients With Essential Hypertension

The purpose of this study is to evaluate the efficacy and safety of AD-209

Condition or disease : hypertension

Inclusion Criteria:

• Signed informed consent
• Other inclusions applied

Exclusion Criteria:

• Orthostatic hypotension with symptom
• Other exclusions applied